Literature DB >> 10220497

Polarized expression and function of the costimulatory molecule CD58 on human intestinal epithelial cells.

P E Framson1, D H Cho, L Y Lee, R M Hershberg.   

Abstract

BACKGROUND & AIMS: Intestinal epithelial cells (IECs) can process foreign protein antigens and display antigenic peptides to CD4(+) T lymphocytes via HLA class II molecules. The purpose of this study was to determine the nature of the second, or costimulatory, signal provided by IECs.
METHODS: We investigated surface expression of the costimulatory molecules CD58 (LFA-3), CD80 (B7-1), and CD86 (B7-2) by using flow cytometry, confocal microscopy, and vectorial biotinylation. Antibodies specific for CD58, CD80, and CD86 were used in blocking experiments to assess the role of these molecules in providing a costimulatory signal to CD4(+) T cells by IECs.
RESULTS: CD58, but not CD80 or CD86, was observed to be expressed constitutively on both native IECs and in the IEC lines T84 and HT-29. The surface expression of CD58 was highly polarized and restricted to the basolateral surface of the cell. Antibodies against CD58, but not CD80 or CD86, inhibited the stimulation of CD4(+) T-cell proliferation mediated by IECs.
CONCLUSIONS: CD58 is expressed by polarized IECs in a topologically restricted manner at the region of T-cell contact and can function as a costimulatory molecule in HLA class II-mediated antigen presentation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10220497     DOI: 10.1016/s0016-5085(99)70008-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  11 in total

Review 1.  Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?

Authors:  Taku Kambayashi; Terri M Laufer
Journal:  Nat Rev Immunol       Date:  2014-10-17       Impact factor: 53.106

Review 2.  Cytokine responses and epithelial function in the intestinal mucosa.

Authors:  Joseph C Onyiah; Sean P Colgan
Journal:  Cell Mol Life Sci       Date:  2016-06-06       Impact factor: 9.261

3.  CD2 activation of human lamina propria lymphocytes reduces CD3 responsiveness.

Authors:  Ellen C Ebert
Journal:  Immunology       Date:  2006-01       Impact factor: 7.397

4.  Human bronchial intraepithelial T cells produce interferon-gamma and stimulate epithelial cells.

Authors:  S Hirosako; E Goto; K Fujii; K Tsumori; N Hirata; S Tsumura; H Kamohara; H Kohrogi
Journal:  Clin Exp Immunol       Date:  2008-11-26       Impact factor: 4.330

5.  Activation of human intraepithelial lymphocytes reduces CD3 expression.

Authors:  E C Ebert
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

6.  Intestinal epithelial exosomes carry MHC class II/peptides able to inform the immune system in mice.

Authors:  G Van Niel; J Mallegol; C Bevilacqua; C Candalh; S Brugière; E Tomaskovic-Crook; J K Heath; N Cerf-Bensussan; M Heyman
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

7.  Interferon-γ induces expression of MHC class II on intestinal epithelial cells and protects mice from colitis.

Authors:  Christoph Thelemann; Remzi Onur Eren; Manuel Coutaz; Jennifer Brasseit; Hanifa Bouzourene; Muriel Rosa; Anais Duval; Christine Lavanchy; Vanessa Mack; Christoph Mueller; Walter Reith; Hans Acha-Orbea
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

Review 8.  Epithelial MHC Class II Expression and Its Role in Antigen Presentation in the Gastrointestinal and Respiratory Tracts.

Authors:  Jonathan E Wosen; Dhriti Mukhopadhyay; Claudia Macaubas; Elizabeth D Mellins
Journal:  Front Immunol       Date:  2018-09-25       Impact factor: 7.561

9.  Human Oral Epithelial Cells Suppress T Cell Function via Prostaglandin E2 Secretion.

Authors:  Jose L Sanchez-Trincado; Hector F Pelaez-Prestel; Esther M Lafuente; Pedro A Reche
Journal:  Front Immunol       Date:  2022-01-19       Impact factor: 7.561

Review 10.  CD58 Immunobiology at a Glance.

Authors:  Yalu Zhang; Qiaofei Liu; Sen Yang; Quan Liao
Journal:  Front Immunol       Date:  2021-06-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.